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Establishment of a Novel iRFP-Incorporated in vivo 
Murine Atherosclerosis Imaging System 
 
Abstract 
By using near-infrared fluorescent protein (iRFP)-expressing hematopoietic 
cells, we established a novel, quantitative, in vivo, noninvasive atherosclerosis 
imaging system. This murine atherosclerosis imaging approach targets macrophages 
expressing iRFP in plaques. Low-density lipoprotein receptor-deficient (LDLR-/-) 
mice transplanted with beta-actin promoter-derived iRFP transgenic (TG) mouse bone 
marrow (BM) cells (iRFP→LDLR-/-) were used. Atherosclerosis was induced by a 
non-fluorescent 1.25% cholesterol diet (HCD). Atherosclerosis was compared among 
the three differently induced mouse groups. iRFP→LDLR-/- mice fed a normal diet 
(ND) and LDLR-/- mice transplanted with wild-type (WT) BM cells were used as 
controls. The in vivo imaging system (IVIS) detected an enhanced iRFP signal in the 
thoracic aorta of HCD-fed iRFP→LDLR-/- mice, whereas iRFP signals were not 
observed in the control mice. Time-course imaging showed a gradual increase in the 
signal area, which was correlated with atherosclerotic plaque progression. Oil red O 
(ORO) staining of aortas and histological analysis of plaques confirmed that the 
detected signal was strictly emitted from plaque-positive areas of the aorta. Our new 
murine atherosclerosis imaging system can noninvasively image atherosclerotic 
plaques in the aorta and generate longitudinal data, validating the ability of the system 
to monitor lesion progression.   
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Chapter 1: General Introduction  
 
1.1 Atherosclerosis  
Atherosclerosis is a pathological condition that plaque builds up inside the 
arteries. Unhealthy blood cholesterol levels, High blood pressure, Smoking, Insulin 
resistance, overweight and obesity, old age and inheritance is considered as the risk 
factors for the onset.1 Plaque is made of cholesterol, fatty substances, cellular 
components, calcium and fibrin. It is initiated by lipid retention, oxidation, and 
chronic inflammation, ultimately causing thrombosis or stenosis.2 Recently 
inflammation and plaque vulnerability have drawn major attention. 
Atherosclerosis is the underlying condition that causes coronary heart disease 
and other cardio vascular diseases (CVD). Despite considerable therapeutic advances 
over the past 50 years, atherosclerosis-related cardiovascular diseases (CVD) remain 
the leading cause of death worldwide3. Conventional structural and functional 
imaging methods play increasingly important roles in better understanding such 
diseases and can be used to validate current therapeutic measures and to develop 
novel drug therapies4. Improved imaging technologies hold promise for accelerating 
drug development3. 
 
1.2 Role of Macrophages in Atherosclerosis 
 Macrophages play essential roles in all phases of atherosclerosis, from the 
development of a fatty streak to processes that ultimately contribute to plaque rupture 
and myocardial infarction5. Leukocytes are central components of the inflammatory 
response, and plaque macrophages account for the majority of leukocytes in 
atherosclerotic plaques6-8. There is extensive evidence linking local macrophage 
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infiltration with plaque characteristics and vulnerability9, and plaque macrophages 
have emerged as key imaging targets for inflammatory atheroma in animal models10-14. 
Consequently, techniques that can detect macrophages in vivo are useful for 
monitoring the development of atherosclerotic lesions. However, to our knowledge, 
there are few reports on direct methods that can be used to noninvasively measure the 
accumulation of macrophages without injecting imaging reagents. Therefore, user-
friendly direct methods to noninvasively detect macrophage-rich plaques are in high 
demand in preclinical settings. 
  
1.3 iRFP and in vivo Imaging of Atherosclerosis 
Bioluminescent proteins and visible light fluorescent proteins are powerful 
technologies that have been extensively used to further our understanding of complex 
biological processes. However, such proteins have limited utility in vivo because of 
their poor deep tissue penetration and high autofluorescence. In contrast, imaging 
with near-infrared fluorescence proteins within the 700-900 nm range of spectral 
wavelengths offers several advantages, including its high-sensitivity, nonionizing 
radiation and relatively simple operation13, 15. A new near-infrared fluorescent protein 
(iRFP), a fluorescent mutant of RpBphP2 bacteriophytochrome, was generated by 
Filonov et al.14. iRFP is a nontoxic, stable protein with excitation and emission 
wavelengths of 690 nm and 713 nm, respectively. iRFP is brighter, stronger and more 
stable than previous generations of similar fluorescent proteins14. These qualities 
make iRFP useful for in vivo imaging with great deep tissue penetration and minimal 
autofluorescence. Previously, Tran et al. generated transgenic (TG) iRFP mice with 
ubiquitous iRFP expression16. The expression of iRFP in hematopoietic cells was also 
observed even in bone marrow-transplanted mice. 
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1.4 Overview and Objectives 
We hypothesized that high iRFP fluorescence could be observed with the 
accumulation of macrophages within the atherosclerotic plaque area after 
transplantation of iRFP TG born marrow cells into X-ray-irradiated low-density 
lipoprotein receptor knockout (LDLR-/-) mice under hyperlipidemia conditions. 
 In this study, we established a noninvasive, in vivo atherosclerosis imaging 
system using iRFP hematopoietic cell-transplanted LDLR-/- mice. To our knowledge, 
this is the first reported use of the endogenous iRFP fluorescence expression to image 
atherosclerotic lesions from 0 to 8 weeks without an invasive method or injection of 
imaging reagents. We believe that this novel noninvasive imaging approach will 
prove to be very helpful for monitoring disease progression in drug intervention 
studies with animal models.           
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Chapter 2: Materials and Methods 
 
2.1 Animals 
All the mice were maintained under specific pathogen-free conditions in 
laboratory animal resource center at the University of Tsukuba. All experiments were 
performed in compliance with relevant Japanese and institutional laws and guidelines 
and were approved by the University of Tsukuba animal ethics committee 
(authorization number 17-156). Previously generated iRFP transgenic mice 
expressing iRFP fluorescence protein under Beta actine promoter and LDLR-/- mice 
were bread and maintained in laboratory animal resource center.  
 
2.2 Mouse Model Generation 
 iRFP TG mice that ubiquitously expressed iRFP by using a beta-actin 
promoter were used16. BM cells were collected from iRFP TG mice. BM cells (1×107) 
were transplanted into 10-12-week-old, lethally X-ray-irradiated (7 Gy) female 
LDLR-/- mice by tail vein injection (3). Eight weeks after transplantation, 
establishment of the transplanted hematopoietic systems in the recipient mice was 
confirmed by testing the peripheral blood chimerism using iRFP fluorescence. Mice 
with chimeras nearly 90% and high were used for further experiments. WT BM cell-
transplanted LDLR-/- mice were used as a negative control (Fig 4). Moreover, 
reconstituted mouse blood parameters were checked before inducing atherosclerosis. 
The iRFP-expressing BM-transplanted mice are abbreviated as iRFP→LDLR-/-, and 
the WT mice, as WT→LDLR-/-. 
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2.3 Chimerism Analysis 
Approximately 300 µl of blood was collected in EDTA-coated tubes from the 
transplanted mice by facial venous puncture. The cells were prepared according to a 
previously published method16. The cells were stained with antigen-presenting cell 
(APC)-conjugated anti-mouse CD 45 antibody (BioLegend, USA) for 30 min, washed, 
and suspended in phosphate-buffered saline (PBS) for analysis with a Gallios flow 
cytometer (Beckman coulter, USA). iRFP fluorescence was detected by the FL7 
(725/20) channel. Chimerism was determined by the percentage of cells that were 
positive for both iRFP and CD 45. 
 
2.4 Atherosclerosis Induction and in vivo Imaging 
 Eight weeks after transplantation, atherosclerosis development was initiated 
by feeding the mice an atherogenic HCD with 1.25% cholesterol (Oriental Yeast Co. 
Ltd, Japan). The diet was especially designed to express no fluorescence (HCD). 
Control groups were fed with a made-to-order non-fluorescent normal diet (ND). The 
live in vivo imaging system (IVIS; Perkin Elmer, USA) was used as the imaging 
device. Live imaging was conducted from day 0 of atherosclerosis induction and 
monitored every 2 weeks. Mice were anesthetized by inhalation anesthesia (Perkin 
Elmer, USA) with isoflurane for induction and anesthesia maintenance during 
imaging. The ventral surface of the body was shaved and subjected to imaging. All 
the IVIS images were acquired with excitation/emission wavelengths of 625/720 nm 
and 710/760 nm and with an exposure time of 1 second (1 s).  
 
 
 
 12 
2.5 Atherosclerotic Area Calculation 
Acquired IVIS images were adjusted to the same minimum and maximum 
values of the color scale by Living Image Software (Perkin Elmer, USA) for 
comparison. The values of the negative controls, which did not show any 
autofluorescence, were selected and set as the minimum (268 counts) and maximum 
(992 counts) values. All the images were normalized to the selected values. In the 
present study, we were only focused on imaging atherosclerotic lesions in the thoracic 
aorta. The region of interest (ROI) was manually traced via Living Image Software. 
Photoshop software (Adobe System, USA) was used to separate the ROIs. The 
specific signal area pixel sizes were measured by the edge detection function of 
ImageJ software (National Institutes of Health, USA). The pixel size was converted to 
area comparing to a pixel size of a known area (Fig. 12). 
 
2.6 Aortic Digestion and Plaque Cell FACS Analysis 
 After 8 weeks of atherosclerosis induction, the iRFP→LDLR-/- and 
WT→LDLR-/- mice were sacrificed by CO2 inhalation. Sacrificed mice were fully 
infused with a slow injection of 20 ml of PBS. Four percent paraformaldehyde (PFA) 
was not used for the perfusion. The aortas were carefully dissected and cleaned. Aorta 
digestion and collection of a single-cell suspension were performed as previously 
published19. The collected cells were washed with PBS and incubated with a 
fluorescein isothiocyanate (FITC)-conjugated anti-mouse F4/80 antibody (Bio-Rad, 
USA) and a phycoerythrin (PE)-conjugated anti-mouse CD11b antibody (Biolegend, 
USA) on ice for 30 min. Cells were washed and resuspended in PBS. FACS analysis 
was carried out using a Gallios flow cytometer (Beckman coulter, USA). Initially, 
F4/80-positive, CD11b-positive cells (macrophages) were gated, and iRFP expression 
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of the double-positive macrophages was detected by the FL7 (725/20) channel. The 
FACS results were analyzed by Kaluza software (Beckman coulter, USA) and FlowJo 
software (FlowJo LLC, USA).  
 
2.7 Ex vivo Macroscopic Analysis of the Aortic Plaque Area 
 We sacrificed mice after 8 weeks of acquiring IVIS images. The aortas were 
carefully dissected and cleaned after slow perfusion with PBS. Ex vivo IVIS images 
of each aorta were acquired shortly after dissection (excitation/emission of 710/760 
nm). We followed a previous method to identify the aortic plaque areas by ORO 
(Wako, Japan) staining32. Briefly, after further cleaning and removal of the adventitia, 
the aortas were fixed overnight in 4% PFA. The aortas were longitudinally opened 
and stained with ORO. Immediately after staining, opened aortas were carefully 
mounted on a black paper and photographed. ORO-positive areas were measured by 
analyzing the images via Photoshop and ImageJ software (Fig. 13).  
 
2.8 Histological Analysis of Atherosclerotic Plaques 
 For the histological analysis of atherosclerosis plaques, dissected hearts were 
fixed in 4% PFA for 4-5 hours and incubated in 30% sucrose at 4°C overnight. Fixed 
hearts were horizontally cut, and the half containing the apex was frozen in optimal 
cutting temperature (O.T.C.) embedding medium (Sakura Finetek, Japan). Serial 
sectioning was performed in the area of the aortic root by cryotome (Leica, Germany). 
Each section was 6 µm thick. Hematoxylin and eosin staining and ORO staining were 
performed as described in established protocols5,16. For immunohistochemical 
analysis of Mac2 expression in the plaque macrophages, frozen sections were 
incubated with a 1:200 dilution of rat anti-mouse Mac2 antibody (Cedarlane, Canada). 
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For secondary fluorescent staining, a 1:500 dilution of Alexa Fluor 488-conjugated 
chicken anti-rat IgG secondary antibody was used (Invitrogen, USA). Stained 
histological sections were observed with a BioRevo fluorescence microscope 
(Keyence, Japan). iRFP fluorescence expression was observed in consecutive, 
unstained sections under a Cy5.5 filter using a fluorescence microscope (Olympus, 
Japan).  
 
2.9 Assessing Macrophage iRFP Expression and Intensity  
 Healthy 2-3-month-old iRFP TG and WT B6 mice were intraperitoneally 
injected with 3 ml of thioglycolate (Becton Dickinson, USA). Three days after the 
injection, the mice were sacrificed, and the accumulated peritoneal macrophages were 
collected in PBS. Serial dilutions of iRFP TG macrophages were made ranging from 
1×103 cells/sample to 1×107 cells/sample. The dilutions were centrifuged, and cell 
pellets were obtained. The fluorescence of the samples was imaged by the IVIS under 
710 nm and 760 nm excitation and emission wavelengths, respectively. WT 
macrophages (1×107) were used as a negative control. The fluorescence intensities of 
different numbers of cells were measured by the Living Image Software and plotted 
against the cell number. Another sample of collected iRFP and WT macrophages 
were washed with PBS, and 1×106 cells were cultured for more than one hour at 37°C 
with DMEM (Life Technologies, USA) containing 10% fetal bovine serum (FBS) 
(Sigma-Aldrich, USA) and 1% penicillin. After incubation, the used medium was 
carefully removed with floating cells, and the adhered macrophages were isolated. 
iRFP expression in the cultured cells were observed under a Cy5.5 filter by a 
fluorescence microscope. (Olympus, Japan) 
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2.10 Statistical Analysis 
All the quantified data are presented as the mean ± s.e.m. The data are from 
one representative experiment of at least two independent experiments. Probability 
values were calculated by Welch’s t-test.  Nonparametric test Spearman's correlation 
coefficient was used for correlation analysis. P values less than 0.05 considered 
significant. 
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Chapter 3: Results 
 
3.1 In vitro Fluorescence Expression of iRFP TG Macrophages 
 Initially, to validate the fluorescence intensity of iRFP TG mouse 
macrophages, we collected peritoneal macrophages from both iRFP TG and wild-type 
(WT) mice 3 days after injection of thioglycolate. Then, the cultured macrophages 
were observed by fluorescence microscope under a Cy5.5 filter. Clear, bright iRFP 
fluorescence signals were observed in the iRFP TG mouse macrophages, while no 
iRFP signal was observed in the WT macrophages (Fig. 1A). Next, we conducted an 
experiment to determine the minimum iRFP TG macrophage number that was 
required to produce a detectable fluorescent signal by IVIS in the in vitro conditions. 
iRFP TG peritoneal macrophages were collected in 0.2 ml tubes at amounts ranging 
from 1×103 cells to 1×107 cells. Clear fluorescence signals were detected even with 
1×105 iRFP TG macrophages, while no fluorescence signal was observed from the 
WT peritoneal macrophages, even at 1×107 cells (Fig. 1B). The signal intensity 
increased exponentially with an augmented number of cells (Fig. 1C). The 
fluorescence signal intensity of 1×107 iRFP TG macrophages was even higher than 
that of indocyanine green, which was used as a positive control. These results 
demonstrate that the iRFP TG macrophages display a bright iRFP signal and that the 
fluorescence intensity increased in a cell number-dependent manner. Moreover, the 
IVIS system was capable of capturing the cellular iRFP signal, and under our imaging 
conditions, a minimum of 1×105 iRFP TG macrophages was required to detect a 
fluorescence signal in vitro. 
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3.2 iRFP TG Macrophage Signal to Noise Ratio 
To evaluate the sensitivity of our imaging system signal to noise ratio of iRFP 
TG macrophages and WT macrophages was measured under the IVIS system. IVIS 
image of 1×107 WT and 1×107 iRFP TG mouse peritoneal macrophages was captured 
under 710 nm and 760 nm excitation and emission wavelengths. Indocyanine Green 
was used as the positive control.  Total Radiant Efficiency [p/s/cm²/sr] / [µW/cm²] 
and Avg Radiant Efficiency [p/s/cm²/sr] / [µW/cm²] was measured by Living Image 
software in WT cell pellet signal area and iRFP cell pellet signal area. Signal-to-
background ratio was calculated as (ROI 2 – ROI 1) / ROI 1, where ROI 1 or ROI 2 
were average radiant efficiencies of the WT macrophages and iRFP macrophages 
respectively (Fig. 2). It was observed that iRFP macrophages shows more than 20 
times high signal to noise ratio compared to WT macrophages. It was measured that 
fluorescent signal of iRFP TG macrophages have mare than 50 times high signal to 
noise ratio compared to background (Data not shown). Theses high signal to noise 
ratio of iRFP TG macrophages suggest that iRFP TG macrophages are a sensitive 
imaging target for our imaging system.  
 
3.3 iRFP→LDLR-/- Mouse Model Hematopoietic System Comprised of iRFP 
Expressing Nucleated Cells 
Because iRFP fluorescence is known to display excellent tissue penetration in 
vivo compared with its previous generations and other fluorescence proteins, we 
hypothesized that iRFP could be used for the in vivo imaging of atherosclerotic 
lesions. First, we transplanted bone marrow (BM) cells of iRFP TG mice into X-ray-
irradiated LDLR-/- mice, which were utilized as an inducible atherosclerosis model17, 
18 (Fig. 3). Two months after transplantation, the reconstitution efficiency of the 
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hematopoietic system was verified by fluorescence-activated cell sorting (FACS) 
analysis of peripheral blood. As shown in Fig. 4, iRFP BM cells transplanted mice 
hematopoietic system was successfully reconstituted with donor derived cells 
showing majority of CD45 + iRFP+ population. WT BM transplanted mice peripheral 
cell exhibit negligible amounts of iRFP expression with CD 45+ iRFP– cell 
population.  Mice showing nearly over 90% chimerism were selected for all further 
experiments.  
 
3.4 Special Non-fluorescent Diets Show Negligible Abdominal Near Infrared 
Autofluorescence 
Next, to induce atherosclerosis in iRFP→LDLR-/- and WT→LDLR-/- mice, we 
fed mice a commercially available normal high-cholesterol diet (N-HCD) and control 
groups were fed with normal mouse chow diet (N-ND).  When the mice were imaged 
under IVIS system after feeding, it was observed that the mouse abdominal area 
shows high intensity strong near infrared fluorescence signals (Fig. 6A-a). Mice were 
sacrificed and dissected to identify the source of the observed fluorescence signal. 
Open abdomen IVIS imaging showed that ingested food in the intestines emits strong 
levels of near infrared autofluorescence (Fig. 6A-b). This high intensity 
autofluorescent abdominal signal could masks the expected thoracic atherosclerosis 
signals. To overcome this problem, high cholesterol diet with 1.25% cholesterol and 
express a negligible level of near-infrared auto fluorescence (HCD) was specially 
formulated (Oriental Yeast Co. Ltd, Japan). Control groups were fed with a made-to-
order non-fluorescent normal diet (ND).  The new non-fluorescent HCD and ND was 
fed to mice and imaged under IVIS system to evaluate the auto fluorescence levels of 
new food. It was observed that new HCD and ND show negligible levels of near 
 19 
infrared autofluorescence compared to N-HCD and N-ND under our imaging 
conditions (Fig. 6B). The use of non-fluorescence diets cut off the food born auto 
fluorescence in the abdominal region.  This prevented the masking of thoracic signal 
by non-specific signals. Finally, adopting to feed non- fluorescence diet facilitated the 
clear detection of thoracic signal and highly enhanced the quality of the imaging 
methodology. 
 
3.5 Atherosclerosis Induced iRFP→LDLR-/- Thoracic Aorta Showed iRFP 
Signals In situ  
Before studying ability of our system to capture signals in vivo, initial studies 
were carried out to observe whether atherosclerosis induction could create any iRFP 
fluorescence signals in mouse aorta and the ability of the IVIS system to capture 
signals in situ.  iRFP→LDLR-/-  mice were fed with HCD to induce atherosclerosis. 
iRFP→LDLR-/-  mice fed with ND and  WT→LDLR-/-  mice fed with HCD were used 
as controls. After 8 weeks of feeding mice were sacrificed and carefully dissected to 
expose thoracic aorta. Mice were then imaged under IVIS system. As shown in Fig. 
7A-a, atherosclerosis induced iRFP→LDLR-/- mouse aorta showed a clear fluorescent 
signal but the control groups aortas were comply negative for any signal. To elucidate 
that the observed signal is essentially from the aorta, but not from the vertebral 
column, aorta was carefully dissected out and mice were imaged. No signal was 
observed after removal of aorta (Fig. 7A-b). The dissected aortas IVIS images showed 
a clear fluorescence signal in atherosclerotic iRFP→LDLR-/- aorta, resembling the 
signal observed in the aorta in situ (Fig. 7B). These results suggest that atherosclerosis 
induction in iRFP→LDLR-/- mice create a specific aortic iRFP signal, which IVIS 
system could detect in situ. 
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3.6 The iRFP Signal is Specific to Atherosclerotic Plaques 
Next the IVIS imaging was carried out to evaluate the imaging systems ability 
to capture the expected thoracic atherosclerosis signal in vivo. IVIS images showed a 
clear iRFP fluorescence signal in the thoracic areas of iRFP→LDLR-/- mice that were 
fed an HCD for 8 weeks (Fig. 8A, right panel). On the other hand, no thoracic iRFP 
fluorescence was observed in iRFP→LDLR-/- mice that were fed a normal diet (ND) 
or in the HCD-fed WT→LDLR-/- mice (Fig. 8A, middle and left panels).  
To confirm that the signal originated from the HCD-induced atherosclerotic 
plaques, we verified the iRFP signals in dissected aortas by the IVIS. Then, the aortas 
were stained with oil red O (ORO) to locate atherosclerosis plaque-positive areas. As 
expected, ex vivo iRFP signals and ORO-positive areas were observed in the aortas of 
the HCD-fed iRFP→LDLR-/- mice. Moreover, the pattern of ORO staining seemed to 
very similar to the iRFP signal in the aorta (Fig. 8B, right panel). Importantly, we 
detected no iRFP signals in the aortas of the HCD-fed WT→LDLR-/- mice or the ND-
fed iRFP→LDLR-/- mice. These results suggested that the iRFP signal was 
specifically emitted from the plaque area (Fig. 8B, left and middle panels). Because 
iRFP signals originate from hematopoietic cells from the BM, we speculated that the 
accumulation of primarily iRFP-baring macrophages and other immune cells in the 
plaques generated the signal. Altogether, these results suggest that our imaging 
system can capture murine atherosclerotic plaque areas in vivo in a noninvasive 
fashion. 
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3.7 Fluorescence Expression Co-localizes with Macrophage-Rich Plaques in 
iRFP-Positive BM-Transplanted Mice 
 To unequivocally demonstrate that the observed fluorescence signals 
originated from macrophage-rich plaque areas, we carried out a histological analysis 
of the atherosclerotic plaques using 16-18-week-old iRFP→LDLR-/- and WT→LDLR-/-
mice fed a HCD for 8 weeks. To determine whether iRFP expression could be 
observed after fixation in the plaques, unstained plaque sections were directly imaged 
under an iRFP-specific 720-nm filter (Fig. 9A). Accumulation of iRFP-positive cells 
(marked with arrows) was clearly observed in the iRFP→LDLR-/- mouse 
atherosclerosis plaques. To determine whether the iRFP-expressing cells were plaque 
macrophages, consecutive sections of aortic root plaques were stained with ORO to 
localize the lipid-rich plaque areas and with an anti-Mac2 antibody to label the 
accumulated plaque macrophages. WT→LDLR-/- mouse plaques were used as the 
negative control. As shown in Fig. 9B, a clear iRFP signal was observed in the Mac2-
positive atherosclerotic lesions, as indicated by ORO staining in the iRFP→LDLR-/- 
mice, whereas a negligibly low signal was observed in the WT-transplanted mouse 
plaques.  
 FACS analysis using adventitia-removed aortas can be used to identify 
immune cells of plaques19. We employed this FACS analysis to determine whether 
macrophages in the plaques express iRFP. CD11b and F4/80 double-positive cells 
(macrophages) were gated in both iRFP→LDLR-/- and iRFP→LDLR-/- digested mouse 
atherosclerotic aorta samples (Fig. 10A). The gating strategy and compensation 
control data are presented in Fig. 11. FACS analysis results showed that the mean 
fluorescence intensity of the iRFP-incorporated plaque macrophages was 
approximately six-fold higher than that of the WT macrophages, whereas compared 
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with the iRFP-expressing plaque macrophages, almost all WT macrophages showed a 
negligibly low level of auto fluorescence (Fig. 10B and C). These results indicated 
high co-localization of plaque macrophages and iRFP signals, implying that our 
imaging system specifically detects macrophage-filled plaques in vivo.  
 
3.8 In vivo Thoracic Signal Calculation in IVIS Images 
In this study, only atherosclerotic lesions in the thoracic aorta were focused. 
The IVIS images were acquired in 710nm/ 760nm excitation and emission 
wavelengths. All the images were normalized to the minimum (268 counts) and 
maximum (992 counts) values. The region of interest (ROI) was manually traced in 
IVIS images via Living Image Software. Clavicle bone and the end of the rib cage 
were used as guides to mark the ROI.  Photoshop software was used to create a gray 
scale images and to crop the ROIs with black signal. The specific signal area was 
mapped by the find edges function of Image J software. Pixels inside the edges were 
measured and converted to area size by comparing to pixels of a known area. The 
quantification method is graphically presented in Fig. 12.    
 
3.9 Thoracic Aorta Oil Red O Staining Positive Area Calculation   
The dissected and cleaned aortas were longitudinally opened and stained with 
ORO. Immediately after staining, opened aortas were carefully mounted on a black 
paper with a use of a clear sticky tape. Special care was given not to roll the aorta and 
to prevent air bubbles accumulation. Perfectly mounted aortas were photographed 
under good light. The captured photograph was used for calculation. Thoracic aorta 
ROI was determined from the beginning of ascending aorta up to the celiac trunk. Red 
color only image was generated by change color function of Photoshop software. 
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Then the red only image was converted to 8 bit black and white image by ImageJ 
software. The specific signal area margins were mapped by the find edges function of 
ImageJ. Pixels inside the edges were measured by measure function in ImageJ and 
converted to area size by comparing to pixels of a known area. The quantification 
steps are graphically presented in Fig. 13.    
 
3.10 The HCD Feeding Amount Positively Correlate with Atherosclerosis Plaque 
Burden  
 Few studies have been published that were able to image the plaque burden in 
animal models in vivo. Most of the time, in vivo imaging of atherosclerosis is limited 
to qualitative rather than quantitative imaging. We therefore assessed the ability of 
our imaging system to visualize differences in the macrophage-rich plaque burden in 
vivo. To induce different quantities of plaques, we adopted a strategy to feed the mice 
different amounts of the HCD, and consequently, the iRFP→LDLR-/- mice were 
divided into three groups. One group was fed with the HCD for the entire 
experimental period and was called the “HCD” group. The second group was fed with 
the HCD and ND on alternating weeks and was named the “HCD/ND” group. The 
third group was fed only the ND, and thus, there was no atherosclerosis induction; 
this group was called the “ND” group (Fig. 5A). After 8 weeks of feeding, the mice in 
the three groups were imaged for atherosclerotic lesions. Then, the mice were 
sacrificed, and ex vivo imaging of the aortas was performed, followed by ORO 
staining. Body weights of mice were measured every two weeks (Table 1). The mean 
body weight distribution in all groups did not showed a significant fluctuation during 
the study period and remained in normal range. These results suggested generally 
equal food intake in all groups and normal physiological weight gain. Blood 
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parameters were checked after 8 weeks of feeding to evaluate the physiological 
condition of mice (Table 2). All the important parameters in all groups were in normal 
physiological range conforming our experimental conditions didn't provoked extreme 
disturbances mouse normal physiological conditions.  
To asses whether our feeding strategy actually generated different levels of 
atherosclerosis induction and plaque burden according to the amount of HCD intake, 
a correlation analysis between the actual plaque positive area (ORO staining area) and 
feeding group was carried out.  As figured in Fig. 14A, aortic ORO-positive areas 
were significantly correlated with the amount of HCD that was fed to the mice, i.e., 
induction percentage (Spearman’s rank correlation = 0.865, (ND) group: n = 3, 
(HCD/ND) group: n = 8, (HCD) group: n = 4, P = 0.01), confirming that the different 
plaque burdens resulted from differences in atherosclerosis induction by the HCD.  
 
3.11 The iRFP Imaging System Visualizes the Macrophage-Rich Plaque Burden 
In vivo 
As shown in Fig. 15A, the highest in vivo thoracic signals were clearly 
observed in the HCD group. Corresponding aortic ex vivo signal areas and ORO-
positive areas could also be detected in this group. Negligible levels of in vivo 
fluorescent signals were observed in the ND group with no ex vivo aortic signals and 
ORO-negative staining. In the HCD/ND group, the observed signal area values were 
between those of the HCD and ND groups. ORO staining of the aortas and aortic 
valves showed that the different HCD feeding patterns induced different extents of 
atherosclerosis in each group, and the observed in vivo iRFP signal areas 
demonstrated a signal distribution corresponding to the actual plaque-positive areas.  
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 As shown in Fig. 15A, the ORO-positive areas and in vivo iRFP signal areas 
were not identical, but closely related.  This minute deviation is resulted from the 
adopted experimental technique that cut and opened aorta was used in   ORO staining, 
while ex vivo IVIS images were taken before cutting and opening the aorta. We 
quantified the actual thoracic plaque area in all groups by measuring the ORO-
positive areas (Fig. 16A). In vivo thoracic iRFP signal-positive areas were also 
quantified (Fig. 16B). The Notably, a significant correlation was observed between 
the iRFP in vivo signal area and the ex vivo ORO-positive plaque area of the aortas 
(Spearman’s rank correlation = 0.782, n = 10, P = 0.01, Fig. 16C). Collectively, these 
results suggest that our iRFP-based imaging system can be used to visualize 
macrophage-rich plaque burden in vivo via IVIS, taking advantage of the thoracic 
iRFP fluorescence signal without any invasive procedures. 
 
3.12 In vivo Thoracic iRFP Fluorescence Signal is Related to Plaque Progression 
 To continuously monitor iRFP fluorescence, IVIS images were acquired every 
two weeks to observe the thoracic signal in the three groups fed different amounts of 
HCD. Fig. 17A shows the disease progression imaging up to 8 weeks after 
atherosclerosis induction. We used ND-fed iRFP→LDLR-/- mice as the negative 
control in each imaging session (denoted by * in Fig. 17A). From the fourth week of 
induction, we observed thoracic signals in the HCD/ND and HCD groups, whereas 
only negligible signals were detected in the ND group. The thoracic iRFP signals 
were clearly observed in the same mice at week 6 and week 8 after induction. As 
expected, the HCD group mice showed the highest signal area, followed by the 
HCD/ND group mice (Fig. 17A). Moreover, we quantified the signal area from weeks 
2 to 8 in the three groups. These data showed that the area of the iRFP signals clearly 
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differed among the HCD group, the HCD/ND group, and the ND group (Fig 17B). 
Overall, these results indicate that our imaging system can clearly capture the time 
course of disease progression in individual mice in a relatively straightforward 
fashion. This system also allows differences in plaque burden to be quantified among 
mice in the same group. 
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Chapter 4: Discussion   
For the first time, this study showed here that endogenous iRFP fluorescence 
as a sensitive marker for imaging deep tissue pathologies, such as aortic 
atherosclerotic lesions. Previously, Min Htun et al. took advantage of the near-
infrared autofluorescence emitted by intra plaque hemorrhage to image vulnerable 
plaques in carotid arteries in vivo20. Though this approach has greatly advanced, it still 
possesses some limitations, as it can only image hemorrhagic plaques and may have 
limited ability for deep tissue imaging due to its dependence on autofluorescence. 
Here, we demonstrate the advanced use of endogenous iRFP fluorescence expression 
in macrophages to visualize plaque development in deep tissues, such as the thoracic 
aorta.  
 The accumulation of iRFP-incorporated macrophages and other immune cells 
in plaques produces a signal that is strong enough to be detected by the IVIS and to 
distinguish lesions from normal tissue. Recent reports show that while 
monocytes/macrophages play a major role in plaque development, the infiltration of 
other cells, such as neutrophils, dendritic cells, B cells and T cells, is also responsible 
for plaque development21. On the other hand, as white blood cells and erythrocyte 
express iRFP in iRFP TG, iRFP signals were detected in capillary-dense regions with 
no hair, such as the paws and the mandible. These signals were suspected to be caused 
by the formation of HCD feeding induced xanthomas, where lipids accumulate in 
large foam cells within the skin. Moreover, either minor fluorescence of red blood 
cells in capillary beds or increased white blood cells derived from inflammation after 
HCD could also partially contribute to this signal (Fig.6, Fig.7A, Fig.8A, Fig.15 and 
Fig.17A)16. However, our FACS analysis data showed that iRFP was predominantly 
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expressed in the F4/80+CD11b+ plaque macrophage population, whereas a very small 
population of F4/80-CD11b- cells express iRFP at negligible intensities (Data not 
shown). Based on these data, it is reasonable to consider that the majority of iRFP 
fluorescence in atherosclerotic plaque originates from macrophages.  
 As monocyte infiltration is the initial event in plaque development22,23, 
incorporating iRFP into the monocyte lineage cells enables plaque detection and the 
observation of plaque-prone areas from a very early stage. Moreover, it has been 
shown that infiltrated macrophages can locally proliferate to increase their number in 
the lesion, and self-proliferation dominates in the advanced stages24,25. In our BMT 
system, iRFP-expressing macrophages from the transplanted hematopoietic system 
infiltrate the initial lesion and initiate a signal. In the event of local proliferation of 
infiltrated macrophages, our system benefits from the fact that locally proliferated 
macrophages also express iRFP fluorescence and contribute to the signal, as iRFP is 
genetically incorporated and can be genetically carried to subsequent generations. 
Thus, a continuous signal is ensured throughout plaque progression.  
  In this study time course iRFP expression of iRFP TG macrophages were not 
tested. There are also not published data on the iRFP expression in macrophages. But, 
Filonov et al showed that iRFP-sorted HeLa cell populations remained mostly within 
the original sorting gates even more than 40 days after transfection. Filonov also 
assess the degradation kinetics of iRFP in HEC 293 cells treated with puromycin to 
inhibit protein translation, and reported that the fluorescence of iRFP protein was 
stable in cells and only around 30% degradation was observed in a period of 20 hours. 
These reports suggest the stable fluorescence expression in iRFP proteins in cells, 
facilitating continuous cellular endogenous fluorescent expression14.  
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Continuous endogenous fluorescent expression enables time course 
monitoring of plaques with real-time longitudinal data generated by the same mice. 
This is greatly beneficial, as it reduces the number of research animals used in a study 
and facilitates data interpretation, as experimental variations are less. Furthermore, 
long-term in vivo observation allows individual differences in disease patterns and 
drug therapy to be studied. As an example, it was reported that the aortic root, the 
lower curvature of the aortic arch, and branch points of the aortic arch are frequent 
predilection sites for initial plaque development26. Though an initial signal is expected 
to be visible in the aortic arch, we found that some mice also showed initial signal 
development in the descending aorta, which may due to individual differences in mice 
with slight differences in predilection sites. In this scenario, our imaging system has 
the advantage allowing plaque formation to be observed in real time. This imaging 
system can be used to observe the general patterns and individual differences in 
predilection sites for atherosclerosis in the thoracic aorta.  
 Most recently, Calcagno et al. successfully demonstrated integrated 18F-FDG 
PET and a dynamic contrast-enhanced (DCE) MRI imaging protocol for 
quantification of several plaque parameters, including plaque inflammation and 
plaque burden, in rabbits27. Though the clinical use of this method is promising, its 
requirements of highly skilled professionals, time, and frequent injections of 
radioactive imaging agents could be unfavorable for preclinical animal study settings. 
Here, we successfully showed that our new imaging system has the capability to 
generate in vivo data on macrophage-rich plaque burden via a comparatively simple 
and feasible approach. However, it must be noted that the observed signal is from 
plaque macrophages and may not represent the whole plaque burden depending on the 
stage of atherosclerosis. Early lesions are rich in macrophages, and severe lesions can 
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show partly non-cellular areas. Our observations confirmed that necrotic core is 
negative for iRFP signals and cellular iRFP expression might be diminishing with cell 
necrosis process. This idea was supported by the published data that majority of the 
sorted mKate2 (cytotoxic standard) treated HeLa cells lost their fluorescence14. 
Therefore, the macrophage-rich plaque area may closely represent the whole plaque 
in the early stages, as shown in our 8-week study, but could be a limitation in 
interpreting the burden in advance plaques. 
 The significant positive correlation observed between the ORO-stained area 
and the in vivo IVIS signal area is advantageous for commenting on the actual plaque 
area based on the IVIS signal. However, the observed correlation coefficient seems 
slightly low, which could be explained by the fact that ORO stains both the foam cell 
lipid accumulations and extracellular lipid deposits, while the fluorescence signal is 
from macrophage foam cells. Moreover, a cut and opened aorta was used in   ORO 
staining, while ex vivo IVIS images were taken before cutting and opening the aorta. 
This can also contribute to configuration changes and may lead to differences in the 
plaque area measurements between the two conditions. Despite of analyzing 
correlation of aortic lesions in whole aorta, comparing exact areas of the aortic lesions 
with the exact comparative in vivo signal would also increase the correlation 
efficiency and the real plaque area prediction precision. 
 In human atherosclerosis, plaque rupture and subsequent thrombosis are the 
main underlying cause of acute cardiovascular outcomes varying from unstable 
angina to sudden death28. It has been reported that plaque vulnerability increases with 
the plaque macrophage population9,29-31. Here, we showed that the number of iRFP 
TG macrophages relates to the iRFP signal intensity. Therefore, with a proper 
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translational approach, we believe that iRFP-based imaging systems could be 
developed to predict human atherosclerosis plaque vulnerability in vivo. 
 From a practical, preclinical point of view, our system is less invasive and less 
hazardous than other existing models that require the injection of imaging 
fluorescent/radioactive dyes at every imaging session. This system can be easily 
modified to acquire greater sensitivity and specificity by using a more sensitive 
detection system, such as photoacoustic imaging. In addition, greater signal 
specificity on the biological side could be achieved by limiting iRFP expression 
specifically in macrophages or, more specifically, in atherosclerotic plaque 
macrophages. Using a macrophage-specific “cre” driver or specifically targeting up 
regulated genes during plaque foam cell formation to incorporate iRFP may be 
successful approaches. Studies evaluating further advancements of the system are 
underway. 
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Chapter 5: Figures and Legends 
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Chapter 6: Tables 
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Chapter 7: Summery and Conclusion 
In conclusion, a method for visualizing atherosclerotic lesions by using iRFP 
fluorescence was developed. The atherosclerotic lesion areas of at least 5 mice were 
evaluated via a one-time detection approach by using an IVIS system noninvasively 
and without any injection reagent. Therefore, this method may be a good system for 
drug discovery or for easily determining the atherosclerosis phenotype of gene-
targeting mice. 
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